Sutton Wealth Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13
| Closed | -$602 | – | 1710 |
|
|
2022
Q3 | $602 | Buy |
+13
| New | +$602 | ﹤0.01% | 1435 |
|
|
2022
Q2 | – | Sell |
-210
| Closed | -$17K | – | 1691 |
|
|
2022
Q1 | $17K | Buy |
210
+170
| +425% | +$13.8K | 0.01% | 764 |
|
|
2021
Q4 | $8.2K | Buy |
40
+3
| +8% | +$615 | ﹤0.01% | 996 |
|
|
2021
Q3 | $10.1K | Hold |
37
| – | – | ﹤0.01% | 905 |
|
|
2021
Q2 | $9.63K | Hold |
37
| – | – | ﹤0.01% | 922 |
|
|
2021
Q1 | $11.2K | Hold |
37
| – | – | ﹤0.01% | 841 |
|
|
2020
Q4 | $9.54K | Hold |
37
| – | – | ﹤0.01% | 822 |
|
|
2020
Q3 | $9.31K | Hold |
37
| – | – | ﹤0.01% | 761 |
|
|
2020
Q2 | $13K | Hold |
37
| – | – | 0.01% | 640 |
|
|
2020
Q1 | $10K | Buy |
+37
| New | +$10K | 0.01% | 652 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1189 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | -$427 | – | 1202 |
|
|
2019
Q2 | $427 | Sell |
1
-1
| -50% | -$427 | ﹤0.01% | 1142 |
|
|
2019
Q1 | $1.01K | Hold |
2
| – | – | ﹤0.01% | 1110 |
|
|
2018
Q4 | $986 | Sell |
2
-8
| -80% | -$3.94K | ﹤0.01% | 1040 |
|
|
2018
Q3 | $8.78K | Sell |
10
-18
| -64% | -$15.8K | 0.01% | 812 |
|
|
2018
Q2 | $20.2K | Buy |
28
+12
| +75% | +$8.64K | 0.01% | 587 |
|
|
2018
Q1 | $25.6K | Sell |
16
-138
| -90% | -$221K | 0.02% | 473 |
|
|
2017
Q4 | $138K | Buy |
154
+28
| +22% | +$25.1K | 0.1% | 165 |
|
|
2017
Q3 | $45.4K | Sell |
126
-14
| -10% | -$5.05K | 0.03% | 293 |
|
|
2017
Q2 | $41.1K | Buy |
140
+2
| +1% | +$587 | 0.03% | 299 |
|
|
2017
Q1 | $48.5K | Buy |
138
+34
| +33% | +$12K | 0.04% | 269 |
|
|
2016
Q4 | $19.1K | Hold |
104
| – | – | 0.02% | 513 |
|
|
2016
Q3 | $26.8K | Hold |
104
| – | – | 0.02% | 386 |
|
|
2016
Q2 | $22.2K | Hold |
104
| – | – | 0.02% | 420 |
|
|
2016
Q1 | $21.4K | Buy |
+104
| New | +$21.4K | 0.02% | 419 |
|